Skip to main content
. 2022 Apr 18;20(4):271. doi: 10.3390/md20040271

Figure 2.

Figure 2

Molecular structure of various phytoplankton-derived toxins with potential therapeutic effects: (a) Lyngbyatoxin; (b) Oscillatoxins; (c) Kalkitoxin; (d) Microcystin; (e) Domoic acid; (f) Iso-domoic acid; (g) Saxitoxin (STX); (h) Tetrodotoxin (TTX); (i) gymnodimines A (GYMA); (j) 13-desmethyl spirolide C; (k) Ciguatoxin; (l) Pectenotoxin; (m) gymnocin-A (GYMA; (n) Azaspiracid-1 (AZA1); (o) Gambierol; (p) Brevetoxin type-A; (q) Brevetoxin type-B.